Three steroid-binding globulins, their localization in the brain and nose, and what they might be doing there.

Corticosteroid binding globulin Estradiol receptor-beta Non-genomic steroid effects Olfactory system Sex hormone binding globulin Vitamin-D binding protein

Journal

Steroids
ISSN: 1878-5867
Titre abrégé: Steroids
Pays: United States
ID NLM: 0404536

Informations de publication

Date de publication:
02 2019
Historique:
received: 23 02 2017
revised: 06 10 2017
accepted: 07 12 2017
pubmed: 17 12 2017
medline: 7 6 2019
entrez: 17 12 2017
Statut: ppublish

Résumé

Steroid-binding globulins (SBGs) such as sex hormone binding globulin, corticosteroid binding globulin, and vitamin-D binding protein are receiving increasing notice as being actively involved in steroid actions. This paper reviews data of all three of these SBGs, focusing on their presence and possible activity in the brain and nose. We have found all three proteins in the brain in limbic areas such as the paraventricular (PVN) and supraoptic nuclei (SON) as well as other areas of the hypothalamus, hippocampus, and medial preoptic area. There is also evidence that all three are made in the PVN and SON, in conjunction with the neuropeptides oxytocin and vasopressin. The localization of these three SBGs is more variable within areas of the main olfactory area and the vomeronasal organ. However, all three are found in the mucus of these areas, suggesting that one of their functions is to sequester aerosol steroids, such as pheromones, and deliver them to sensory cells and then to deeper sensory areas. In this manuscript, we present multiple models of SBG action including: A) SBG binding to a membrane receptor, B) this SBG receptor being associated with a larger protein complex including cytoplasmic steroid receptors, C) when the SBGs binds to their SBG receptors, second messengers within the cells respond, D) after SBG binding to its receptor, it releases its associated steroid into the membrane's lipid bilayer, from which it gains access into the cell only when bound by an internal protein, E) the SBG, possibly with its bound SBG receptor, is internalized into the cell from which it can gain access to numerous organelles and possibly the cell's nucleus or F) associate with intracellular steroid receptors, G) SBGs produced in target cells are released from those cells upon specific stimulation, and H) according to the Free Steroid Hypothesis steroids released from the extracellular SBG passively diffuse across the plasma membrane of the cell. These models move the area of steroid endocrinology forward by providing important paths of steroid activity within many steroid target cells.

Identifiants

pubmed: 29246492
pii: S0039-128X(17)30230-1
doi: 10.1016/j.steroids.2017.12.004
pii:
doi:

Substances chimiques

Sex Hormone-Binding Globulin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

48-54

Informations de copyright

Copyright © 2017 Elsevier Inc. All rights reserved.

Auteurs

J D Caldwell (JD)

Department of Pharmacology, Edward Via College of Osteopathic Medicine and Gibbs Research Center, 350 Howard Street, Spartanburg, SC, USA. Electronic address: jcaldwell@carolinas.vcom.edu.

K Londe (K)

Department of Pharmacology, Edward Via College of Osteopathic Medicine and Gibbs Research Center, 350 Howard Street, Spartanburg, SC, USA.

S D Ochs (SD)

Department of Pharmacology, Edward Via College of Osteopathic Medicine and Gibbs Research Center, 350 Howard Street, Spartanburg, SC, USA.

Z Hajdu (Z)

Department of Pharmacology, Edward Via College of Osteopathic Medicine and Gibbs Research Center, 350 Howard Street, Spartanburg, SC, USA.

A Rodewald (A)

Institute of Anatomy, Anatomy II, Jena University Hospital, Jena, Germany.

V M Gebhart (VM)

Institute of Anatomy, Anatomy II, Jena University Hospital, Jena, Germany.

G F Jirikowski (GF)

Institute of Anatomy, Anatomy II, Jena University Hospital, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH